GATA1 is highly expressed in pancreatic ductal adenocarcinoma (PDAC) tissues, and GATA1 status is an independent predictor of prognosis and response to gemcitabine therapy. The gene discussed is GATA1; the disease is pancreatic ductal adenocarcinoma.